Next-generation CRISPR technology can now target specific neurons in brain tissue, exhibiting a level of single-cell precision that was previously thought to be impossible. This opens doors for gene therapies that target neurological disorders with precision and specificity, having the potential to treat Alzheimer’s, Parkinson’s and even epilepsy.
Could this be executed with the precision it claims?
Will this change the game in biotechnology?
What are your thoughts?